RenovoRx, Inc.
USD0.97
+0.03 (+2.79%)
CEO
Shaun R. Bagai
IPO Date
2021-08-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.95
Prev. Close
$0.94
Day Low
$0.94
Day High
$0.97
52W Low
$0.70
52W High
$1.45
Market Cap
$0.04B
Volume
0.14M
| -3.5 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | 341.1% | -698.0% | 0.00 | 1.25 | -4.6 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -160.5% | -136.1% | 0.00 | 6.59 | -4.3 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -41.2% | -38.8% | 0.00 | 17.36 | -13.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 25.9% | -198.4% | -0.19 | 0.47 | -33.1 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -262.0% | -169.1% | 0.00 | 2.81 | -32.8 |
| -2.5 |
| 30 Sept 2025 | Q3 | 80.1% | -1094.7% | -36.0% | -26.0% | 0.03 | 5.83 | -4.0 |
| 30 Jun 2025 | Q2 | 64.0% | -686.0% | -27.2% | -21.2% | 0.02 | 8.61 | -4.2 |
| 31 Mar 2025 | Q1 | 52.3% | -1228.4% | -18.4% | -15.1% | 0.02 | 9.07 | -3.2 |
| 31 Dec 2024 | Q4 | 100.0% | -6693.0% | -64.3% | -35.5% | 0.06 | 4.10 | -2.5 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -34.9% | -24.6% | 0.00 | 5.66 | -2.7 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -25.8% | -19.9% | 0.00 | 9.16 | -2.9 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -60.9% | -22.5% | 0.00 | 1.54 | -9.2 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | 107.6% | -220.1% | 0.00 | 1.25 | -3.8 |